Hyperlipidemia

For patient information click here Template:DiseaseDisorder infobox

WikiDoc Resources for Hyperlipidemia
Articles
Most recent articles on Hyperlipidemia Most cited articles on Hyperlipidemia Review articles on Hyperlipidemia Articles on Hyperlipidemia in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Hyperlipidemia Images of Hyperlipidemia Photos of Hyperlipidemia Podcasts & MP3s on Hyperlipidemia Videos on Hyperlipidemia
Evidence Based Medicine
Cochrane Collaboration on Hyperlipidemia Bandolier on Hyperlipidemia TRIP on Hyperlipidemia
Clinical Trials
Ongoing Trials on Hyperlipidemia at Clinical Trials.gov Trial results on Hyperlipidemia Clinical Trials on Hyperlipidemia at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Hyperlipidemia NICE Guidance on Hyperlipidemia NHS PRODIGY Guidance FDA on Hyperlipidemia CDC on Hyperlipidemia
Books
Books on Hyperlipidemia
News
Hyperlipidemia in the news Be alerted to news on Hyperlipidemia News trends on Hyperlipidemia
Commentary
Blogs on Hyperlipidemia
Definitions
Definitions of Hyperlipidemia
Patient Resources / Community
Patient resources on Hyperlipidemia Discussion groups on Hyperlipidemia Patient Handouts on Hyperlipidemia Directions to Hospitals Treating Hyperlipidemia Risk calculators and risk factors for Hyperlipidemia
Healthcare Provider Resources
Symptoms of Hyperlipidemia Causes & Risk Factors for Hyperlipidemia Diagnostic studies for Hyperlipidemia Treatment of Hyperlipidemia
Continuing Medical Education (CME)
CME Programs on Hyperlipidemia
International
Hyperlipidemia en Espanol Hyperlipidemia en Francais
Business
Hyperlipidemia in the Marketplace Patents on Hyperlipidemia
Experimental / Informatics
List of terms related to Hyperlipidemia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Hyperlipidemia, hyperlipoproteinemia or dyslipidemia is the presence of raised or abnormal levels of lipids and/or lipoproteins in the blood. Lipids (fatty molecules) are transported in a protein capsule, and the density of the lipids and type of protein determines the fate of the particle and its influence on metabolism.

Lipid and lipoprotein abnormalities are extremely common in the general population, and are regarded as a highly modifiable risk factor for cardiovascular disease due to the influence of cholesterol, one of the most clinically relevant lipid substances, on atherosclerosis. In addition, some forms may predispose to acute pancreatitis.

Hyperlipidemia screening

Target population | Screening tests | Screening frequency

Treatment

NCEP recommendations for children and adolescents with high-risk hyperlipidemia

Recommendations for drug therapy | Statins | Adjuvant therapies

External links

• The Fredrickson papers (with photos from early lipoprotein research)
• Template:GPnotebook

Hyperlipoproteinemia	OMIM	GPnotebook	WebMD	Others
Type I	Online Mendelian Inheritance in Man (OMIM) 238600	Template:GPnotebook	.	MeritCare
Type IIa	Online Mendelian Inheritance in Man (OMIM) 144400	Template:GPnotebook	.	Merck
Type IIb		Template:GPnotebook	.
Type III	.	Template:GPnotebook	WebMD	Yahoo
Type IV	Online Mendelian Inheritance in Man (OMIM) 144600	Template:GPnotebook	WebMD	Yahoo
Type V	Online Mendelian Inheritance in Man (OMIM) 144600	Template:GPnotebook	.	.

Template:WikiDoc Sources